Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia

European Journal of Pharmacology

Volumn 436, Issue 1-2, 2002, Pages 145-150

  Ortlepp, J R ^a   Breuer, J ^a   Eitner, F ^a   Kluge, K ^a   Kluge, R ^a   Floege, J ^a   Hollweg, G ^a   Hanrath, P ^a   Joost, H G ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

(Mouse); Angiotensin AT1 receptor; Angiotensin converting enzyme inhibitor; Hyperinsulinemia; Metabolic syndrome; Obesity

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART VENTRICLE HYPERTROPHY; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; CARDIOMEGALY; FEMALE; HYPERINSULINISM; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; TIME FACTORS;

EID: 0036468328     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01587-4     Document Type: Article

References (28)

1. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo - Evidence for a regulatory role of endothelin
2. Angiotensin II receptors in human preadipocytes: Role in cell cycle regulation
3. Growth characteristics, glucose tolerance and insulin sensitivity of New Zealand obese mice
4. The effect of Nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
5. Laboratory animals exhibiting obesity and diabetes syndromes
6. Hyperleptinemia, leptin resistance and polymorphic leptin receptor in the New Zealand obese (NZO) mouse
7. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells
8. Angiotensinogen gene expression in adipose tissue: Analysis of obese models and nutritional control
9. Insulin-mediated growth in aortic smooth muscle and the renin-angiotensin system
10. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in E-deficient mice
11. Enhanced atherosclerosis and kidney dysfunction in eNOS-/-ApoE-/-mice are ameliorated by enalapril treatment
12. Obesity - Impact on cardiovascular disease
13. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
14. A metabolic syndrome of hypertension, hyperinsulinemia, and hypercholesterinemia in the New Zealand (NZO) mouse
15. Variation in the susceptibility to atherosclerosis among inbred strains of mice
16. Quantitative assessment of atherosclerotic lesions in mice
17. Evidence that macrophages in atherosclerotic lesions contain angiotensin II
18. Atherosclerosis - An inflammatory disease
19. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men
20. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high cholesterol fed cynomolgus monkeys
21. The effects of the renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits
22. Accerelation of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system
23. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial (FACET) in patients with hypertension and NIDDM
24. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients
25. Intensive blood-glucose with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
26. Evolution of insulin resistance in New Zealand obese mice
27. 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits
28. Effect of the ACE inhibitor Lisinopril on mortality in diabetic patients with acute myocardial infarction